The Department of Health helps to protect the community from the potential harm of medicines and chemicals. One way it does this is through controls defined in Victorian Drugs, Poisons and Controlled Substances legislation.
This legislation is applicable to substances that are listed in the Australian Standard for the Uniform Scheduling of Medicines and Poisons.
Victorian legislative controls for these substances vary according to their risk. Some of these controls include:
- Defining who is authorised to lawfully possess certain scheduled substances
- Requirements for the storage of scheduled substances
- Requirements for prescribing and supplying scheduled medicines
The Department also monitors and responds to legislative non-compliance.
Commonly used online forms
If you have issues registering with SafeScript or logging in SafeScript, please contact SafeScript technical support on 1800 723 379.
Schedule 9 permits for clinical trials
Legislative requirements and process for obtaining S9 permits in human clinical trials.
Patient Schedule 8 treatment permits
Legislative requirements for medical practitioners and nurse practitioners wishing to obtain permits to prescribe Schedule 8 medicines and warrants to prescribe selected Schedule 4 poisons.
Schedule 8 MDMA and Schedule 8 psilocybine
Information and legislative requirements for Schedule 8 MDMA and Schedule 8 psilocybine
Licences and permits to possess (and possibly supply) scheduled substances
Apply for, or change a licence or permit to possess (and possibly supply) scheduled substances. [May be used in industry and health]
Medicines and poisons recent updates
Latest updates in the medicine and poisons sector including changes to regulatory requirements, authorisations, emergency supply and monitoring of specific items.
Frequently Asked Questions – Medicines and Poisons Regulation
This page contains answers to the most frequently asked questions.
Legislation and approvals
Includes medications in aged care, poisons code, approvals by Minister and Secretary, synthetic cannabinoids and e-cigarettes.
Pharmacotherapy (opioid replacement therapy)
Opioid replacement therapy. Legislative requirements and policies associated with the use of methadone and buprenorphine in the provision of opioid-replacement therapy.
Documents and forms to print or download – medicines and poisons regulation
Summaries of legislative requirements and related forms for different health practitioners.
Reviewed 20 June 2023